Lyell, Juno veteran Albertson becomes Caribou’s CMO
Plus: 10x names CCO, CFO and updates from Ovid, Cerevance, Fore, Atavistik, Velia, SpyBiotech, Telomir, Sernova and Holoclara
Caribou Biosciences Inc. (NASDAQ:CRBU) hired Tina Albertson as CMO, to lead the company’s four clinical programs for hematologic malignancies and autoimmune diseases. Albertson was CMO and head of development for Lyell Immunopharma Inc. (NASDAQ:LYEL), and VP of global drug development at Juno Therapeutics, now part of Bristol Myers Squibb Co. (NYSE:BMY).
10x Genomics Inc. (NASDAQ:TXG) named Mennah Moustafa as chief commercial officer and Adam Taich as CFO. Taich, who was chief strategy officer of Standard BioTools Inc. (NASDAQ:LAB), succeeds CFO Justin McAnear, who will resign from 10x on Aug. 30 to join an undisclosed private company. Moustafa joined 10x in 2022 as SVP of commercial operations and has served as the company's interim CCO since January...